{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:17:31Z","timestamp":1781090251749,"version":"3.54.1"},"reference-count":59,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T00:00:00Z","timestamp":1158624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2006,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p> <jats:italic>Background:<\/jats:italic> Inflammatory, medium to severe acne vulgaris is treated with systemic antibiotics worldwide. The rationale is an effect on <jats:italic>Propionibacterium acnes<\/jats:italic> as well as the intrinsic anti\u2010inflammatory properties of these antibiotics. Although there are no correlations between the number of <jats:italic>P. acnes<\/jats:italic> and the severity of the disease, associations between the degree of humoral and cellular immune responses towards <jats:italic>P. acnes<\/jats:italic> and the severity of acne have been reported. Exact data on practical use of these compounds, such as differential efficacy or side effects are unavailable.A summary of currently available studies is presented.<\/jats:p><jats:p> <jats:italic>Methods:<\/jats:italic> The data of studies of systemic antibiotic therapy of acne vulgaris up to 1975, the summary of literature in English up to 1999, a systematic review of minocycline from 2002 as well as the data of randomized controlled studies published and listed in Medline thereafter were reviewed.<\/jats:p><jats:p> <jats:italic>Results:<\/jats:italic> Tetracyclines [tetracycline 1 000 mg daily, doxycycline 100 (\u2212200) mg daily, minocycline 100 (\u2212200) mg daily, lymecycline 300 (\u2212600) mg] and erythromycin 1 000 mg daily are significantly more effective than placebo in the systemic treatment of inflammatory acne.The data for tetracycline are best founded. Clindamycin is similarly effective. Co\u2010trimoxazole and trimethoprim are likely to be effective. Clear differences between the tetracyclines or between tetracycline and erythromycin cannot be ascertained. The data for the combination with topical treatments [topical benzoyl peroxide (BPO) or retinoids] suggest synergistic effects.Therefore systemic antibiotics should not be used as monotherapy.<\/jats:p><jats:p>In case of similar efficacy, other criteria, such as pharmacokinetics (doxycycline, minocycline, lymecycline have longer half\u2010lives than tetracyclines), the rate of side\u2010effects (tetracycline: side effect\u2010rate \u223c4 % mild side effects; erythromycin: frequent gastrointestinal complaints; minocycline: rare, but potentially severe hypersensitivity reactions; doxycycline: dose\u2010dependent phototoxic reactions), the resistance rate [percentage of resistant bacteria higher with erythromycin (\u223c 50 %) than with tetracycline\u2010therapy (\u223c 20 %)], and the costs of therapy have to be taken into account.<\/jats:p><jats:p> <jats:italic>Conclusions:<\/jats:italic> The systemic antibiotic therapy of widespread papulo\u2010pustular acne not amenable to a topical therapy is effective and well\u2010tolerated. In general therapy can be carried out for 3 months and should be combined with BPO to prevent resistance.<\/jats:p>","DOI":"10.1111\/j.1610-0387.2006.06053.x","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T13:14:39Z","timestamp":1158671679000},"page":"828-841","source":"Crossref","is-referenced-by-count":48,"title":["Systemic antibiotic therapy of acne vulgaris"],"prefix":"10.1111","volume":"4","author":[{"given":"Falk","family":"Ochsendorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,9,19]]},"reference":[{"key":"e_1_2_19_2_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.110901"},{"key":"e_1_2_19_3_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.618"},{"key":"e_1_2_19_4_2","first-page":"391","article-title":"European recommendations on the use of oral antibiotics for acne","volume":"14","author":"Dreno B","year":"2004","journal-title":"Eur J Dermatol"},{"key":"e_1_2_19_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2005.05516.x"},{"key":"e_1_2_19_6_2","unstructured":"JappeU.Akne und Propionibakterien. Deutscher Dermatologe2002:583\u20139."},{"key":"e_1_2_19_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12264715"},{"key":"e_1_2_19_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1963.01590240156026"},{"key":"e_1_2_19_9_2","first-page":"205","article-title":"The microbial colonization of inflamed acne vulgaris lesions","volume":"18","author":"Leeming JP","year":"1988","journal-title":"Br J Dermatol"},{"key":"e_1_2_19_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.4.459"},{"key":"e_1_2_19_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06614.x"},{"key":"e_1_2_19_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12321.x"},{"key":"e_1_2_19_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12550_6.x"},{"key":"e_1_2_19_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2004.05762.x"},{"key":"e_1_2_19_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06530.x"},{"key":"e_1_2_19_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2006.05901.x"},{"key":"e_1_2_19_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-001-0334-4"},{"key":"e_1_2_19_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000063358"},{"key":"e_1_2_19_19_2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D304975508","article-title":"Anti\u2010inflammatory effects of Erythromycin and Tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils","volume":"8","author":"Jain A","year":"2002","journal-title":"Dermatology Online Journal"},{"key":"e_1_2_19_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.10.004"},{"key":"e_1_2_19_21_2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/archderm.1975.01630240086015","article-title":"Systemic antibiotics for treatment of acne vulgaris: efficacy and safety","volume":"111","author":"Report AHC","year":"1975","journal-title":"Arch Dermatol"},{"key":"e_1_2_19_22_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120912"},{"key":"e_1_2_19_23_2","volume-title":"The Cochrane Library","author":"Garner SE","year":"2002"},{"key":"e_1_2_19_24_2","volume-title":"Management of Acne (Evidence Report\/Technology Assessment No. 17 (Prepared by Johns Hopkins Evidence\u2010based Practice Center under Contract No. 290\u201097\u2010006)","author":"Lehmann HP","year":"2001"},{"key":"e_1_2_19_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17591-0"},{"key":"e_1_2_19_26_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)01153-8"},{"key":"e_1_2_19_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006059602400114"},{"key":"e_1_2_19_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2004.tb00496.x"},{"key":"e_1_2_19_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2001.tb00077.x"},{"key":"e_1_2_19_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2005.01769.x"},{"key":"e_1_2_19_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000063365"},{"key":"e_1_2_19_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70079-6"},{"key":"e_1_2_19_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1989.tb08194.x"},{"key":"e_1_2_19_34_2","first-page":"121","article-title":"Topical vitamin A acid (Airol) and systemic oxytetracycline in the treatment of acne vulgaris","volume":"149","author":"Christiansen JV","year":"1974","journal-title":"A controlled clinical trial. Dermatologica"},{"key":"e_1_2_19_35_2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/archderm.1972.01620110036009","article-title":"Acne vulgaris. Oral therapy with tetracycline and topical therapy with vitamin A","volume":"106","author":"Mills OHJ","year":"1972","journal-title":"Arch Dermatol"},{"key":"e_1_2_19_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2005.04279.x"},{"key":"e_1_2_19_37_2","first-page":"538","article-title":"Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne","volume":"11","author":"Gollnick HP","year":"2001","journal-title":"Eur J Dermatol"},{"key":"e_1_2_19_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.291.6504.1231"},{"key":"e_1_2_19_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)80192-9"},{"key":"e_1_2_19_40_2","doi-asserted-by":"publisher","DOI":"10.1159\/000049398"},{"key":"e_1_2_19_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1992.tb00198.x"},{"key":"e_1_2_19_42_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304120-00002"},{"key":"e_1_2_19_43_2","first-page":"2755","article-title":"[Oral tetracycline\u2013treatment of acne. Rapid facial improvement, but back lesions are more difficult to treat]","volume":"90","author":"Mobacken H","year":"1993","journal-title":"Lakartidningen"},{"key":"e_1_2_19_44_2","unstructured":"CampoM ZuluagaA EscobarP et al.A comparative study on the effectiveness of lymecrcline and adapalene versus minocycline and adapalene in the treatment of acne vulgaris. In:Proceedings 20th World Congress of Dermatology. 1\u20135 July 2002. Paris France 2002:P0005."},{"key":"e_1_2_19_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05067.x"},{"key":"e_1_2_19_46_2","doi-asserted-by":"publisher","DOI":"10.1159\/000067822"},{"key":"e_1_2_19_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.4.467"},{"key":"e_1_2_19_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(02)00017-6"},{"key":"e_1_2_19_49_2","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2003.74.5.669"},{"key":"e_1_2_19_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb06972.x"},{"key":"e_1_2_19_51_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.9.1132"},{"key":"e_1_2_19_52_2","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/archderm.1997.03890460044005","article-title":"Comparative safety of tetracycline, minocycline and doxycycline","volume":"133","author":"Shapiro LE","year":"1997","journal-title":"Arch Dermatol"},{"key":"e_1_2_19_53_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018387"},{"key":"e_1_2_19_54_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017847"},{"key":"e_1_2_19_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1993.tb02242.x"},{"key":"e_1_2_19_56_2","first-page":"662","article-title":"Doxycycline\u2010 induced photo\u2010onycholysis","volume":"2","author":"Carroll LA","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_19_57_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05389.x"},{"key":"e_1_2_19_58_2","first-page":"1","volume":"18","author":"ACOG. The use of hormonal contraception in women with coexisting medical conditions","year":"2000","journal-title":"ACOG Prac Bull"},{"key":"e_1_2_19_59_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120448"},{"key":"e_1_2_19_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(85)70064-3"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1610-0387.2006.06053.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1610-0387.2006.06053.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T18:04:25Z","timestamp":1697047465000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1610-0387.2006.06053.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,19]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["10.1111\/j.1610-0387.2006.06053.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1610-0387.2006.06053.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,19]]}}}